Company Filing History:
Years Active: 2025
Title: Christian Specker: Innovator in Pharmaceutical Chemistry
Introduction
Christian Specker is a notable inventor based in Hochdorf, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on substituted pyrazine-carboxamide derivatives. His research focuses on compounds that have therapeutic potential, especially in relation to metabotropic glutamate receptor subtype 4 (mGluR4).
Latest Patents
Christian Specker holds 1 patent for his invention titled "Substituted pyrazine-carboxamide derivatives." This patent details a process for manufacturing these compounds, as well as their pharmaceutical compositions and therapeutic applications. The compounds are designed to treat and/or prevent conditions associated with the function of mGluR4, showcasing their potential in medical therapies.
Career Highlights
Christian Specker is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at this esteemed organization has allowed him to further his research and development efforts in the pharmaceutical sector.
Collaborations
Throughout his career, Christian has collaborated with esteemed colleagues, including Roland Pfau and Georg Dahmann. These collaborations have enriched his research and contributed to the advancement of pharmaceutical innovations.
Conclusion
Christian Specker's contributions to pharmaceutical chemistry, particularly through his patented work on substituted pyrazine-carboxamide derivatives, highlight his role as an innovator in the field. His ongoing research and collaborations continue to pave the way for advancements in therapeutic applications.